Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Title:
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Author:
Harbeck, N. Rastogi, P. Martin, M. Tolaney, S.M. Shao, Z.M. Fasching, P.A. Huang, C.S. Jaliffe, G.G. Tryakin, A. Goetz, M.P. Rugo, H.S. Senkus, E. Testa, L. Andersson, M. Tamura, K. Del Mastro, L. Steger, G.G. Kreipe, H. Hegg, R. Sohn, J. Guarneri, V. Cortés, J. Hamilton, E. André, V. Wei, R. Barriga, S. Sherwood, S. Forrester, T. Munoz, M. Shahir, A. San Antonio, B. Nabinger, S.C. Toi, M. Johnston, S.R.D. O’Shaughnessy, J.